PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2012

Synergistic protection against hyperoxia-induced lung injury by neutrophils blockade and EC-SOD overexpression.

Mouse / Other

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 22816678 ↗2012Reported benefit

Synergistic protection against hyperoxia-induced lung injury by neutrophils blockade and EC-SOD overexpression.

MouseOtherB6C3 background; transgenic mice carrying an extra copy of human EC-SOD under the SP-C promoter, and wild type littermatesn = 10 pups per group across 8 groups; 5 animals per group used…Intraperitoneal injectionAntileukinate 100 microgram/g body weight in 0.1 ml 0.9% w/…First dose given at birth as soon as litters were born, before the start of hyp…

Model: Hyperoxia-induced neonatal lung injury (95% FiO2 for 7 days from birth), compared with room air

Antileukinate significantly reduced bronchoalveolar neutrophil counts, myeloperoxidase activity, albumin leak and 8-isoprostane, and increased the reduced to oxidised glutathione ratio in both wild type and transgenic pups after hyperoxia. Antileukinate-treated transgenic pups showed significantly…

Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.